Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
19
Number of overlapping holdings
23.2%
% of FXH's 83 holdings also in WDNA
21.3%
% of WDNA's 91 holdings also in FXH
Overlap by Weight
Sector Drift (FXH minus WDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FXH |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
 |
NATERA INC | 2.1% | 1.9% | 1.9% |
|
ELI LILLY & CO | 2.1% | 1.9% | 1.9% |
|
REGENERON PHARMACEUTICALS | 1.2% | 1.2% | 1.2% |
|
MERCK & CO. INC. | 1.2% | 1.1% | 1.1% |
|
UNITED THERAPEUTICS CORP | 2.3% | 1.0% | 1.0% |
Position Highlights (Non-Overlapping Exposures)
FXH Overweight Relative to WDNA
|
SHOCKWAVE MEDICAL, INC. | 2.3% |
 |
ROIVANT SCIENCES LTD. | 2.2% |
|
CIGNA CORPORATION | 2.2% |
|
CARDINAL HEALTH INC | 2.2% |
|
REPROS THERAPEUTICS INC | 2.2% |
|
ENCOMPASS HEALTH CORPORATION | 2.1% |
|
PREMIER INC-CLASS A | 2.1% |
|
VIATRIS, INC. | 2.1% |
|
DAVITA INC | 2.1% |
|
MEDPACE HOLDINGS, INC. | 2.1% |
FXH Underweight Relative to WDNA
|
IOVANCE BIOTHERAPEUTICS INC | -3.9% |
|
TWIST BIOSCIENCE CORP. | -3.4% |
|
FATE THERAPEUTICS INC | -3.1% |
 |
NOVOZYMES A/S-B SHARES | -2.4% |
|
BLUEPRINT MEDICINES CORP. | -2.2% |
|
BRIDGEBIO PHARMA, INC. | -2.0% |
|
CRISPR THERAPEUTICS AG | -1.8% |
 |
ALCOBRA LTD | -1.7% |
|
VERICEL CORPORATION | -1.7% |
|
AGIOS PHARMACEUTICALS INC | -1.6% |